#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia (in remission) Oropharyngeal cancer recurrent Rett syndrome Pleomorphic leiomyosarcoma Lung adenocarcinoma Neuroendocrine carcinoma of the skin Chondrosarcoma metastatic Congenital growth hormone deficiency Blastic plasmacytoid dendritic cell neoplasia Mantle cell lymphoma stage II Malignant peritoneal neoplasm Proteus syndrome B-cell small lymphocytic lymphoma refractory Small cell lung cancer limited stage Adenocarcinoma pancreas More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome – Basic Information Proteus syndrome – Trials in Disease Pemphigus – Treatment Hypereosinophilic syndrome – Diagnostics Undifferentiated sarcoma Uterine leiomyosarcoma – Trials in Disease Sarcoidosis – Treatment Stevens-Johnson syndrome – Life with Disease Krabbe’s disease – Life with Disease Paraneoplastic neurological syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Quemliclustat Autogene Cevumeran Thymalfasin Elasomeran Pertechnetate (99Mtc) Sodium M1P Dipotassium Salt SODIUM SELENITE PENTAHYDRATE POTASSIUM CLAVULANATE Guselkumab Vx-522 Ruxotemitide ANOC-001 Incb000928 Paracetamol Navtemadlin Granisetron Daxdilimab Pioglitazone Blomia Tropicalis Stro-002 More therapies…

    Learn about Your Condition

    Oesophageal food impaction Ovarian cancer Gastric cancer stage IV Fatty acid oxidation disorder Post-traumatic stress disorder Thrombolysis Anaemia of chronic disease Chronic coronary syndrome Obstructive pancreatitis Coronary artery dissection Infantile spasms Short stature Systemic candida Postoperative delirium Renal injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Haematological malignancy

  • Study of fludarabine phosphate in patients with blood cancer undergoing lymphodepletion before CAR-T cell therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Brexucabtagene Autoleucel
    • Tisagenlecleucel
    • Axicabtagene Ciloleucel
    Belgium

  • Study Comparing High-Dose and Standard-Dose Inactivated Influenza Vaccines in Adults with Blood Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • A/Victoria/2570/2019 (H1N1)Pdm09-Like Strain (A/Victoria/2570/2019, Ivr-215)
    • INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
    • INFLUENZA VIRUS A/DARWIN/9/2021 IVR-228 (H3N2)
    Belgium

  • Study on Fecal Microbiota Transplantation to Prevent Complications in Patients After Stem Cell Transplant for Blood Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    • Haematological malignancy
    Investigated Drugs:
    • Allogeneic Faecal Microbiota
    France

  • Study on the Safety and Effectiveness of SMART101 for Patients Undergoing Stem Cell Transplantation for Blood Cancers

    Recruiting

    2 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    • Haematological malignancy
    Investigated Drugs:
    • Allogeneic T-Cell Precursors, Mobilized Peripheral Blood-Derived, Ex Vivo Cultured
    France Italy

  • Study on the Safety and Effects of Karonudib for Patients with Advanced Leukemia, Lymphoma, and Multiple Myeloma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Idarubicin Hydrochloride
    Denmark Sweden

  • Long-term Safety Study of CRISPR CAR T Cell Therapy for Patients with Blood and Solid Cancers

    Recruiting

    1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Allogeneic Crispr/Cas9-Mediated Genetically Modified Car T Cells Targeting Cd19 Antigen
    Germany
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!